CDMO0.00%14.3%
CRL+73.43%14.3%
DGX+36.32%14.3%
FTRE+189.51%14.3%
LH+20.36%14.3%
MRVI+214.99%14.3%
NOTV0.00%14.3%
As of Aug 6, 2026, 4:25 AM ET
MedTech Long '24: Lab Research & Trials Constituents
Avid Bioservices, Inc.CDMO | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $361.4M |
Charles River Laboratories International, Inc.CRL | 14.3% | 11.36% | 15.07% | 12.66% | 12.13% | 30.70% | 46.07% | 74.65% | 73.43% | $12.56B |
Fortrea Holdings Inc.FTRE | 14.3% | 5.89% | -2.41% | 6.72% | -0.63% | 10.43% | 77.71% | 153.66% | 189.51% | $1.80B |
Inotiv, Inc.NOTV | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $553.0M |
Labcorp Holdings Inc.LH | 14.3% | 0.52% | 5.79% | 10.40% | 1.54% | 25.14% | 8.59% | 32.83% | 20.36% | $25.74B |
Maravai LifeSciences Holdings, Inc.MRVI | 14.3% | -0.31% | -5.18% | 8.64% | -2.44% | 97.23% | 80.06% | 190.05% | 214.99% | $1.77B |
Quest Diagnostics IncorporatedDGX | 14.3% | 0.91% | 3.50% | 10.94% | 1.21% | 35.91% | 11.29% | 41.10% | 36.32% | $26.03B |
| Theme return | — | 2.62% | 2.40% | 7.17% | 1.65% | 29.89% | 31.12% | 75.64% | 64.77% | — |
| Average | 14.3% | 2.62% | 2.40% | 7.05% | 1.69% | 28.49% | 31.96% | 70.33% | 76.37% | $9.83B |
| Median | 14.3% | 0.52% | 0.00% | 8.64% | 0.00% | 25.14% | 11.29% | 41.10% | 36.32% | $1.80B |
| Std Dev | 0.0% | 4.08% | 6.16% | 4.78% | 4.43% | 31.04% | 33.00% | 69.13% | 83.18% | $10.88B |
| Min | 14.3% | -0.31% | -5.18% | 0.00% | -2.44% | 0.00% | 0.00% | 0.00% | 0.00% | $361.4M |
| Max | 14.3% | 11.36% | 15.07% | 12.66% | 12.13% | 97.23% | 80.06% | 190.05% | 214.99% | $26.03B |
| % Positive Tickers | 57.14% | 42.86% | 71.43% | 42.86% | 71.43% | 71.43% | 71.43% | 71.43% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
MedTech Long '24: Lab Research & Trials tracks 7 publicly listed stocks in this theme: CDMO, CRL, DGX, FTRE, LH, MRVI, NOTV. See the constituent table for details.